» Articles » PMID: 31634840

A Novel Approach to Detecting Epistasis Using Random Sampling Regularisation

Overview
Specialty Biology
Date 2019 Oct 22
PMID 31634840
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Epistasis is a progressive approach that complements the 'common disease, common variant' hypothesis that highlights the potential for connected networks of genetic variants collaborating to produce a phenotypic expression. Epistasis is commonly performed as a pairwise or limitless-arity capacity that considers variant networks as either variant vs variant or as high order interactions. This type of analysis extends the number of tests that were previously performed in a standard approach such as Genome-Wide Association Study (GWAS), in which False Discovery Rate (FDR) is already an issue, therefore by multiplying the number of tests up to a factorial rate also increases the issue of FDR. Further to this, epistasis introduces its own limitations of computational complexity and intensity that are generated based on the analysis performed; to consider the most intense approach, a multivariate analysis introduces a time complexity of O(n!). Proposed in this paper is a novel methodology for the detection of epistasis using interpretable methods and best practice to outline interactions through filtering processes. Using a process of Random Sampling Regularisation which randomly splits and produces sample sets to conduct a voting system to regularise the significance and reliability of biological markers, SNPs. Preliminary results are promising, outlining a concise detection of interactions. Results for the detection of epistasis, in the classification of breast cancer patients, indicated eight outlined risk candidate interactions from five variants and a singular candidate variant with high protective association.

Citing Articles

Next-Gen GWAS: full 2D epistatic interaction maps retrieve part of missing heritability and improve phenotypic prediction.

Carre C, Carluer J, Chaux C, Estoup-Streiff C, Roche N, Hosy E Genome Biol. 2024; 25(1):76.

PMID: 38523316 PMC: 10962106. DOI: 10.1186/s13059-024-03202-0.


A Study and Analysis of Disease Identification using Genomic Sequence Processing Models: An Empirical Review.

Ahuja S, Shrimankar D, Durge A Curr Genomics. 2024; 24(4):207-235.

PMID: 38169652 PMC: 10758128. DOI: 10.2174/0113892029269523231101051455.


Genetic interactions effects for cancer disease identification using computational models: a review.

Manavalan R, Priya S Med Biol Eng Comput. 2021; 59(4):733-758.

PMID: 33839998 DOI: 10.1007/s11517-021-02343-9.


The Role of SNP Interactions when Determining Independence of Novel Signals in Genetic Association Studies-An Application to and Bronchodilator Response.

Walsh R, Voorhies K, McDonald M, McGeachie M, Sordillo J, Lange C J Pers Med. 2021; 11(2).

PMID: 33669563 PMC: 7922125. DOI: 10.3390/jpm11020145.